Global Digoxin 麻豆原创 Insights, Forecast to 2030

Publication ID:

PB507246828

Publication Date:

July 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Digoxin is used chronically in the therapy of cardiac arrhythmias, especially atrial fibrillation, atrial flutter and heart failure. It is the most effective medicine for the treatment of heart failure, and a third line medication in the treatment of irregular heartbeat. It is normally administered orally as tabs but can also be given intravenously under urgent circumstances.
The global Digoxin market is projected to grow from US$ 62 million in 2024 to US$ 74 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
North America is the largest Digoxin market with about 37% market share. Asia-Pacific is follower, accounting for about 23% market share.The key players are C2 Pharma, Alkaloids Corporation, Vital Labs, Alchem etc. Top 3 companies occupied about 88% market share.
Report Covers:
This report presents an overview of global market for Digoxin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Digoxin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Digoxin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Digoxin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Digoxin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Digoxin sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Vital Labs
Alchem
Segment by Type
Purity Above 98%
Purity Below 98%
Segment by Application
Tablet Product
Injection Product
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Digoxin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Digoxin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digoxin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Digoxin Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Digoxin 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Purity Above 98%
1.2.3 Purity Below 98%
1.3 麻豆原创 by Application
1.3.1 Global Digoxin 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Tablet Product
1.3.3 Injection Product
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Digoxin Sales Estimates and Forecasts 2019-2030
2.2 Global Digoxin Revenue by Region
2.2.1 Global Digoxin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Digoxin Revenue by Region (2019-2024)
2.2.3 Global Digoxin Revenue by Region (2025-2030)
2.2.4 Global Digoxin Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Digoxin Sales Estimates and Forecasts 2019-2030
2.4 Global Digoxin Sales by Region
2.4.1 Global Digoxin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Digoxin Sales by Region (2019-2024)
2.4.3 Global Digoxin Sales by Region (2025-2030)
2.4.4 Global Digoxin Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Digoxin Sales by Manufacturers
3.1.1 Global Digoxin Sales by Manufacturers (2019-2024)
3.1.2 Global Digoxin Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Digoxin in 2023
3.2 Global Digoxin Revenue by Manufacturers
3.2.1 Global Digoxin Revenue by Manufacturers (2019-2024)
3.2.2 Global Digoxin Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Digoxin Revenue in 2023
3.3 Global Key Players of Digoxin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Digoxin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Digoxin 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Digoxin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Digoxin, Product Offered and Application
3.8 Global Key Manufacturers of Digoxin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Digoxin Sales by Type
4.1.1 Global Digoxin Historical Sales by Type (2019-2024)
4.1.2 Global Digoxin Forecasted Sales by Type (2025-2030)
4.1.3 Global Digoxin Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Digoxin Revenue by Type
4.2.1 Global Digoxin Historical Revenue by Type (2019-2024)
4.2.2 Global Digoxin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Digoxin Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Digoxin Price by Type
4.3.1 Global Digoxin Price by Type (2019-2024)
4.3.2 Global Digoxin Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Digoxin Sales by Application
5.1.1 Global Digoxin Historical Sales by Application (2019-2024)
5.1.2 Global Digoxin Forecasted Sales by Application (2025-2030)
5.1.3 Global Digoxin Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Digoxin Revenue by Application
5.2.1 Global Digoxin Historical Revenue by Application (2019-2024)
5.2.2 Global Digoxin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Digoxin Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Digoxin Price by Application
5.3.1 Global Digoxin Price by Application (2019-2024)
5.3.2 Global Digoxin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Digoxin 麻豆原创 Size by Type
6.1.1 US & Canada Digoxin Sales by Type (2019-2030)
6.1.2 US & Canada Digoxin Revenue by Type (2019-2030)
6.2 US & Canada Digoxin 麻豆原创 Size by Application
6.2.1 US & Canada Digoxin Sales by Application (2019-2030)
6.2.2 US & Canada Digoxin Revenue by Application (2019-2030)
6.3 US & Canada Digoxin 麻豆原创 Size by Country
6.3.1 US & Canada Digoxin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Digoxin Sales by Country (2019-2030)
6.3.3 US & Canada Digoxin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Digoxin 麻豆原创 Size by Type
7.1.1 Europe Digoxin Sales by Type (2019-2030)
7.1.2 Europe Digoxin Revenue by Type (2019-2030)
7.2 Europe Digoxin 麻豆原创 Size by Application
7.2.1 Europe Digoxin Sales by Application (2019-2030)
7.2.2 Europe Digoxin Revenue by Application (2019-2030)
7.3 Europe Digoxin 麻豆原创 Size by Country
7.3.1 Europe Digoxin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Digoxin Sales by Country (2019-2030)
7.3.3 Europe Digoxin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Digoxin 麻豆原创 Size
8.1.1 China Digoxin Sales (2019-2030)
8.1.2 China Digoxin Revenue (2019-2030)
8.2 China Digoxin 麻豆原创 Size by Application
8.2.1 China Digoxin Sales by Application (2019-2030)
8.2.2 China Digoxin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Digoxin 麻豆原创 Size by Type
9.1.1 Asia Digoxin Sales by Type (2019-2030)
9.1.2 Asia Digoxin Revenue by Type (2019-2030)
9.2 Asia Digoxin 麻豆原创 Size by Application
9.2.1 Asia Digoxin Sales by Application (2019-2030)
9.2.2 Asia Digoxin Revenue by Application (2019-2030)
9.3 Asia Digoxin Sales by Region
9.3.1 Asia Digoxin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Digoxin Revenue by Region (2019-2030)
9.3.3 Asia Digoxin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Digoxin 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Digoxin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Digoxin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Digoxin 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Digoxin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Digoxin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Digoxin Sales by Country
10.3.1 Middle East, Africa and Latin America Digoxin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Digoxin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Digoxin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 C2 Pharma
11.1.1 C2 Pharma Company Information
11.1.2 C2 Pharma Overview
11.1.3 C2 Pharma Digoxin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 C2 Pharma Digoxin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 C2 Pharma Recent Developments
11.2 Alkaloids Corporation
11.2.1 Alkaloids Corporation Company Information
11.2.2 Alkaloids Corporation Overview
11.2.3 Alkaloids Corporation Digoxin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Alkaloids Corporation Digoxin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alkaloids Corporation Recent Developments
11.3 Vital Labs
11.3.1 Vital Labs Company Information
11.3.2 Vital Labs Overview
11.3.3 Vital Labs Digoxin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Vital Labs Digoxin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Vital Labs Recent Developments
11.4 Alchem
11.4.1 Alchem Company Information
11.4.2 Alchem Overview
11.4.3 Alchem Digoxin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Alchem Digoxin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Alchem Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Digoxin Industry Chain Analysis
12.2 Digoxin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Digoxin Production Mode & Process
12.4 Digoxin Sales and 麻豆原创ing
12.4.1 Digoxin Sales Channels
12.4.2 Digoxin Distributors
12.5 Digoxin Customers
13 麻豆原创 Dynamics
13.1 Digoxin Industry Trends
13.2 Digoxin 麻豆原创 Drivers
13.3 Digoxin 麻豆原创 Challenges
13.4 Digoxin 麻豆原创 Restraints
14 Key Findings in The Global Digoxin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.